| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| EXELExelixis, Inc. | 11.81B | 44.06 | 15.85 | 6.98% | 29.63% | 31.37% | 7.49% | 0.08 |
| INCYIncyte Corporation | 20.1B | 101.27 | 15.80 | 21.22% | 25.03% | 24.9% | 6.74% | 0.01 |
| GMABGenmab A/S | 18.13B | 29.44 | 15.36 | 30.67% | 46.8% | 114.25% | 6.6% | 0.03 |
| SNDXSyndax Pharmaceuticals, Inc. | 1.89B | 21.71 | -5.82 | -279.31% | -269.93% | 1.20 | ||
| RCUSArcus Biosciences, Inc. | 2.55B | 20.37 | -6.19 | -4.26% | -142.91% | -55.94% | 0.16 | |
| RLAYRelay Therapeutics, Inc. | 1.78B | 10.26 | -6.37 | 53.44% | -18.01% | -48.76% | 0.06 | |
| STROSutro Biopharma, Inc. | 1.74B | 20.47 | -6.92 | -59.64% | -205.18% | -234.19% | 4.57 | |
| OLMAOlema Pharmaceuticals, Inc. | 1.66B | 24.20 | -11 | -48.77% | 0.00 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.91M | 2.51M | 21.91M | 33.5M | 27.76M | 24.51M | 43.15M | 38.84M | 39.81M | 34.88M |
| Revenue Growth % | 46.2% | 31.76% | 773.11% | 52.86% | -17.15% | -11.69% | 76.02% | -9.99% | 2.5% | -12.38% |
| Cost of Goods Sold | 16.18M | 18.42M | 34.13M | 47.81M | 49.64M | 57.33M | 86.27M | 9.95M | 10.5M | 21.92M |
| COGS % of Revenue | 849.4% | 734.02% | 155.72% | 142.7% | 178.85% | 233.91% | 199.94% | 25.63% | 26.38% | 62.85% |
| Gross Profit | -14.28M | -15.91M | -12.21M | -14.31M | -21.88M | -32.82M | -43.12M | 28.88M | 29.31M | 12.96M |
| Gross Margin % | -749.4% | -634.02% | -55.72% | -42.7% | -78.85% | -133.91% | -99.94% | 74.37% | 73.62% | 37.15% |
| Gross Profit Growth % | -39.1% | -11.47% | 23.28% | -17.17% | -52.97% | -49.99% | -31.37% | 166.98% | 1.46% | -55.78% |
| Operating Expenses | 8.84M | 11.97M | 23.09M | 25.62M | 30.41M | 29.29M | 35.93M | 178.34M | 171.11M | 275.58M |
| OpEx % of Revenue | 463.78% | 476.77% | 105.37% | 76.49% | 109.56% | 119.5% | 83.28% | 459.21% | 429.84% | 790.11% |
| Selling, General & Admin | 937K | 4.83M | 14.32M | 25.62M | 28.8M | 29.29M | 35.93M | 48.75M | 54.2M | 79.96M |
| SG&A % of Revenue | 49.19% | 192.23% | 65.37% | 76.49% | 103.78% | 119.5% | 83.28% | 125.52% | 136.15% | 229.24% |
| Research & Development | 16.18M | 18.42M | 34.13M | 52.17M | 53.65M | 62.25M | 94.44M | 148.23M | 132.75M | 229.9M |
| R&D % of Revenue | 849.4% | 734.02% | 155.72% | 155.73% | 193.3% | 253.95% | 218.88% | 381.68% | 333.49% | 659.14% |
| Other Operating Expenses | -8.28M | -11.28M | -25.36M | -52.17M | -52.05M | -62.25M | -94.44M | -18.64M | -15.85M | -34.28M |
| Operating Income | -23.11M | -27.88M | -35.3M | -39.93M | -52.29M | -62.11M | -79.05M | -149.46M | -141.8M | -262.63M |
| Operating Margin % | -1213.18% | -1110.8% | -161.09% | -119.19% | -188.41% | -253.41% | -183.22% | -384.84% | -356.22% | -752.96% |
| Operating Income Growth % | -32.67% | -20.64% | -26.62% | -13.11% | -30.96% | -18.78% | -27.27% | -89.06% | 5.12% | -85.21% |
| EBITDA | -22.92M | -27.65M | -34.98M | -39.27M | -51.28M | -60.93M | -77.75M | -148.26M | -139.5M | -260.24M |
| EBITDA Margin % | -1203.04% | -1101.47% | -159.63% | -117.23% | -184.75% | -248.59% | -180.2% | -381.75% | -350.44% | -746.12% |
| EBITDA Growth % | -33.5% | -20.63% | -26.54% | -12.25% | -30.58% | -18.83% | -27.6% | -90.69% | 5.91% | -86.55% |
| D&A (Non-Cash Add-back) | 193K | 234K | 318K | 658.17K | 1.01M | 1.18M | 1.3M | 1.2M | 2.3M | 2.39M |
| EBIT | -18.69M | -26.39M | -34.26M | -39.93M | -50.69M | -62.11M | -79.05M | -149.46M | -141.8M | -262.63M |
| Net Interest Income | -158.53K | 92.55K | 1.11M | 2.13M | 1.89M | 300K | -129K | 2.72M | 14.51M | 30.79M |
| Interest Income | 54.66K | 92.55K | 1.33M | 2.13M | 1.89M | 300K | 0 | 2.72M | 14.51M | 30.79M |
| Interest Expense | 213.19K | 0 | 227.94K | 0 | 0 | 0 | 129K | 0 | 0 | 0 |
| Other Income/Expense | -145K | -19.56M | -29.22M | 15.4M | 3.3M | -7.48M | 20.56M | 27.83M | 4.35M | 62.64M |
| Pretax Income | -23.26M | -47.44M | -64.53M | -24.53M | -48.99M | -69.59M | -58.49M | -121.63M | -137.45M | -199.99M |
| Pretax Margin % | -1220.79% | -1889.92% | -294.43% | -73.23% | -176.52% | -283.91% | -135.58% | -313.17% | -345.3% | -573.37% |
| Income Tax | 0 | 0 | 249K | 178.94K | 172.95K | 411.75K | 209.99K | 895.61K | 2.89M | 7.87M |
| Effective Tax Rate % | 100% | 100% | 100.39% | 100.73% | 100.35% | 100.59% | 100.36% | 100.74% | 102.1% | 103.93% |
| Net Income | -23.26M | -47.44M | -64.77M | -24.71M | -49.17M | -70M | -58.7M | -122.52M | -140.34M | -207.85M |
| Net Margin % | -1220.79% | -1889.92% | -295.57% | -73.77% | -177.15% | -285.59% | -136.06% | -315.48% | -352.56% | -595.93% |
| Net Income Growth % | -33.59% | -103.98% | -36.55% | 61.85% | -98.96% | -42.37% | 16.14% | -108.71% | -14.55% | -48.1% |
| Net Income (Continuing) | -23.26M | -47.44M | -64.77M | -24.71M | -49.17M | -70M | -58.7M | -122.52M | -140.34M | -207.85M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.65 | -3.75 | -3.81 | -1.28 | -2.28 | -2.92 | -1.73 | -2.92 | -3.00 | -3.35 |
| EPS Growth % | -20.44% | -127.27% | -1.6% | 66.4% | -78.13% | -28.07% | 40.75% | -68.79% | -2.74% | -11.67% |
| EPS (Basic) | -1.65 | -3.75 | -3.81 | -1.28 | -2.28 | -2.92 | -1.73 | -2.92 | -3.00 | -3.35 |
| Diluted Shares Outstanding | 15.41M | 13.23M | 19.2M | 22.29M | 24.22M | 29.26M | 38.64M | 44.92M | 51.61M | 64.22M |
| Basic Shares Outstanding | 15.41M | 13.23M | 19.2M | 22.29M | 24.22M | 29.26M | 38.64M | 44.92M | 51.61M | 64.22M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 37.74M | 74.8M | 225.7M | 223.79M | 247.37M | 217.99M | 424.18M | 306.44M | 368.81M | 569.07M |
| Cash & Short-Term Investments | 35.92M | 59.86M | 220.41M | 215.74M | 239.76M | 207.75M | 410.43M | 290.23M | 355.18M | 537.03M |
| Cash Only | 35.92M | 59.86M | 179.57M | 164.43M | 197.61M | 163.08M | 241.44M | 147.75M | 205.05M | 293.29M |
| Short-Term Investments | 0 | 0 | 40.84M | 51.31M | 42.15M | 44.67M | 168.99M | 142.48M | 150.13M | 243.73M |
| Accounts Receivable | 10.93K | 1.23M | 3.78M | 4.86M | 2.65M | 1.75M | 6.67M | 4.7M | 3.98M | 4.71M |
| Days Sales Outstanding | 2.09 | 179.39 | 62.9 | 52.92 | 34.88 | 26.04 | 56.45 | 44.15 | 36.5 | 49.29 |
| Inventory | 0 | 12.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | 246.84 | - | - | - | - | - | - | - | - |
| Other Current Assets | 372.82K | 113.58K | 0 | 1.08M | 1.38M | 1.06M | 2.17M | 2.2M | 727K | 1.72M |
| Total Non-Current Assets | 1.07M | 1.25M | 10.4M | 26.18M | 16.01M | 13.22M | 32.42M | 70.1M | 86.68M | 213.62M |
| Property, Plant & Equipment | 355.32K | 681.5K | 1.4M | 2.77M | 8.93M | 8.02M | 7.28M | 24.84M | 23.5M | 20.02M |
| Fixed Asset Turnover | 5.36x | 3.68x | 15.64x | 12.10x | 3.11x | 3.06x | 5.92x | 1.56x | 1.69x | 1.74x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 475.59K | 393.34K | 374.31K | 2.8M | 2.88M | 2.84M | 2.35M | 1.95M | 1.8M | 1.68M |
| Long-Term Investments | 0 | 0 | 8.47M | 19.38M | 2.01M | 0 | 20.3M | 36.46M | 57.31M | 187.01M |
| Other Non-Current Assets | 238.34K | 175.63K | 154.76K | 1.23M | 1.91M | 1.95M | 2.08M | 4.81M | 2.87M | 953K |
| Total Assets | 38.81M | 76.05M | 236.11M | 249.96M | 263.38M | 231.22M | 456.6M | 376.54M | 455.49M | 785.13M |
| Asset Turnover | 0.05x | 0.03x | 0.09x | 0.13x | 0.11x | 0.11x | 0.09x | 0.10x | 0.09x | 0.04x |
| Asset Growth % | 801.48% | 95.97% | 210.47% | 5.87% | 5.37% | -12.21% | 97.48% | -17.53% | 20.97% | 72.37% |
| Total Current Liabilities | 6.91M | 8.15M | 22.46M | 33.14M | 36.79M | 46.75M | 71.9M | 78.93M | 69.09M | 87.08M |
| Accounts Payable | 2.42M | 2.3M | 3.43M | 3.24M | 3.03M | 3.13M | 13.24M | 9.83M | 4.6M | 4.16M |
| Days Payables Outstanding | 54.57 | 45.53 | 36.64 | 24.73 | 22.27 | 19.9 | 56.01 | 360.62 | 159.96 | 69.33 |
| Short-Term Debt | 182.58K | 175.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.7M |
| Deferred Revenue (Current) | 1.66M | 1.93M | 8.66M | 19.37M | 18.84M | 20.18M | 34.66M | 29.42M | 22.68M | 29.93M |
| Other Current Liabilities | 589.77K | 231.38K | 535.07K | 207.45K | 21K | 11K | 1.11M | 38K | 35K | 103K |
| Current Ratio | 5.46x | 9.17x | 10.05x | 6.75x | 6.72x | 4.66x | 5.90x | 3.88x | 5.34x | 6.54x |
| Quick Ratio | 5.46x | 7.64x | 10.05x | 6.75x | 6.72x | 4.66x | 5.90x | 3.88x | 5.34x | 6.54x |
| Cash Conversion Cycle | - | 380.71 | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 957.73K | 32.1M | 156.2M | 111.73M | 95.29M | 82.21M | 68.5M | 50.56M | 30.06M | 47.69M |
| Long-Term Debt | 531.34K | 335.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 3.87M | 2.52M | 2.26M | 11.79M | 10.49M | 8.21M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 1.11M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | -1.11M | 0 | 0 | 0 | 0 |
| Total Liabilities | 7.86M | 40.26M | 178.65M | 144.87M | 132.08M | 128.95M | 140.4M | 129.49M | 99.15M | 134.77M |
| Total Debt | 713.93K | 511.13K | 0 | 0 | 5.25M | 3.95M | 3.75M | 13.47M | 12.16M | 9.91M |
| Net Debt | -35.2M | -59.35M | -179.57M | -164.43M | -192.36M | -159.13M | -237.68M | -134.28M | -192.88M | -283.38M |
| Debt / Equity | 0.02x | 0.01x | - | - | 0.04x | 0.04x | 0.01x | 0.05x | 0.03x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -108.40x | - | -154.87x | - | - | - | -612.81x | - | - | - |
| Total Equity | 30.94M | 35.79M | 57.45M | 105.09M | 131.3M | 102.26M | 316.2M | 247.06M | 356.34M | 647.93M |
| Equity Growth % | 814.98% | 15.67% | 60.52% | 82.93% | 24.94% | -22.12% | 209.2% | -21.87% | 44.24% | 81.83% |
| Book Value per Share | 2.01 | 2.71 | 2.99 | 4.72 | 5.42 | 3.50 | 8.18 | 5.50 | 6.91 | 10.09 |
| Total Shareholders' Equity | 30.94M | 35.79M | 57.45M | 105.09M | 131.3M | 102.26M | 316.2M | 247.06M | 356.34M | 647.93M |
| Common Stock | 847.31K | 1.52M | 2.1M | 2.37M | 2.92M | 3.21M | 4.48M | 4.75M | 5.88M | 6.96M |
| Retained Earnings | -69.3M | -112.84M | -200.93M | -259.45M | -314.6M | -400.11M | -466.93M | -598.12M | -753.06M | -968.39M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 1.59M | 9.07M | -9.22M | -30.45M | -22.53M | -55.47M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -25.18M | -27.06M | -44.88M | -46.33M | -63.05M | -79.9M | -59.63M | -149.9M | -142.21M | -185.84M |
| Operating CF Margin % | -1321.78% | -1078.22% | -204.81% | -138.29% | -227.16% | -325.98% | -138.2% | -385.97% | -357.24% | -532.8% |
| Operating CF Growth % | -41.95% | -7.48% | -65.85% | -3.21% | -36.09% | -26.73% | 25.37% | -151.39% | 5.13% | -30.68% |
| Net Income | -25.35M | -49.67M | -87.69M | -27.76M | -55.15M | -85.51M | -66.82M | -131.19M | -154.94M | -215.33M |
| Depreciation & Amortization | 211.01K | 246.1K | 381.5K | 729.81K | 1.14M | 1.44M | 1.49M | 1.28M | 2.54M | 2.47M |
| Stock-Based Compensation | 619.9K | 3.48M | 15.37M | 9.07M | 7.83M | 9.37M | 17.09M | 24.54M | 26.23M | 45.83M |
| Deferred Taxes | -213.19K | 20.53M | 31.63M | -7.07M | -89K | -122K | -7K | -1.62M | 842K | -321K |
| Other Non-Cash Items | 158.53K | -34.7K | -1.25M | -1.35M | -1.6M | 9M | -27.25M | -23.93M | 8.88M | -42.81M |
| Working Capital Changes | -608.97K | -1.62M | -3.33M | -19.94M | -15.18M | -14.08M | 15.87M | -18.97M | -25.75M | 24.32M |
| Change in Receivables | -892.13K | -1.44M | -2.2M | -2.95M | 633K | 1.15M | -4.99M | 1.83M | 1.73M | 1.07M |
| Change in Inventory | 516.04K | 181.94K | 6.23M | -743.54K | 2.29M | 4.13M | 0 | 0 | 0 | 0 |
| Change in Payables | 10.93K | -127.25K | 605.85K | 706.93K | 22K | -110K | 10.71M | -3.92M | -3.93M | -136K |
| Cash from Investing | -57.95K | -429.09K | -49.94M | -22.21M | 24.17M | -1.49M | -146.62M | 2.8M | -27.02M | -220.22M |
| Capital Expenditures | -112.61K | -521.64K | -868.58K | -4.21M | -2.6M | -1.29M | -870K | -7.64M | -3.98M | -1.67M |
| CapEx % of Revenue | 5.91% | 20.78% | 3.96% | 12.56% | 9.36% | 5.25% | 2.02% | 19.67% | 10% | 4.78% |
| Acquisitions | 0 | 0 | 0 | 0 | 375K | 162.9K | 0 | 52K | 52K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 54.66K | 92.55K | 1.11M | 1.46M | -375K | -162.9K | 0 | -52K | -52K | -163K |
| Cash from Financing | 59.44M | 52.8M | 223.41M | 60.86M | 74.23M | 39.52M | 281.95M | 58.74M | 230.09M | 494.01M |
| Debt Issued (Net) | 8.56M | -175.63K | -583.05K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 60.13K | -188.25K | 134.33M | 0 | 48K | 1.45M | 16.85M | 999K | 4.14M | 36.53M |
| Net Change in Cash | 34.2M | 25.31M | 111.29M | -6.78M | 33.08M | -34.53M | 78.47M | -93.31M | 56.58M | 89.02M |
| Free Cash Flow | -25.29M | -27.59M | -45.75M | -50.53M | -65.65M | -81.19M | -60.5M | -157.54M | -146.19M | -187.5M |
| FCF Margin % | -1327.69% | -1099.01% | -208.78% | -150.84% | -236.52% | -331.23% | -140.22% | -405.64% | -367.24% | -537.58% |
| FCF Growth % | -41.07% | -9.06% | -65.86% | -10.45% | -29.91% | -23.68% | 25.49% | -160.41% | 7.2% | -28.26% |
| FCF per Share | -1.64 | -2.09 | -2.38 | -2.27 | -2.71 | -2.78 | -1.57 | -3.51 | -2.83 | -2.92 |
| FCF Conversion (FCF/Net Income) | 1.08x | 0.57x | 0.69x | 1.87x | 1.28x | 1.14x | 1.02x | 1.22x | 1.01x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 320K | 322K | 635K | 0 | 3.1M | 2.8M |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -174.76% | -142.17% | -138.94% | -30.41% | -41.6% | -59.94% | -28.06% | -43.5% | -46.52% | -41.39% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | -547.69% | -117.19% | -77% | -74.61% |
| Gross Margin | -749.4% | -634.02% | -55.72% | -42.7% | -78.85% | -133.91% | -99.94% | 74.37% | 73.62% | 37.15% |
| Net Margin | -1220.79% | -1889.92% | -295.57% | -73.77% | -177.15% | -285.59% | -136.06% | -315.48% | -352.56% | -595.93% |
| Debt / Equity | 0.02x | 0.01x | - | - | 0.04x | 0.04x | 0.01x | 0.05x | 0.03x | 0.02x |
| Interest Coverage | -108.40x | - | -154.87x | - | - | - | -612.81x | - | - | - |
| FCF Conversion | 1.08x | 0.57x | 0.69x | 1.87x | 1.28x | 1.14x | 1.02x | 1.22x | 1.01x | 0.89x |
| Revenue Growth | 46.2% | 31.76% | 773.11% | 52.86% | -17.15% | -11.69% | 76.02% | -9.99% | 2.5% | -12.38% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics